Table Of Contents
1. Market Context & Strategic Relevance
1.1 Opening Context (Why the market matters)
1.1.1 Why This Market Is Gaining Strategic Attention
1.1.2 Business Decisions This Report Supports
1.2 Scope
1.3 Research & Methodology
2. Executive Summary
2.1 Market Snapshot
2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035
2.3 Market Size & Forecast, By Segmentation, 2022–2035
2.3.1 Market Size By Product
2.3.2 Market Size By Technology/Platform
2.3.3 Market Size By Sample Type
2.3.4 Market Size By End User
2.3.5 Market Size By Mode of Purchase
2.4 Market Share & Bps Analysis By Region, 2025
2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic
2.6 Industry CxO’s Perspective
3. Market Overview
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Key Market Trends
3.2 Industry PESTLE Analysis
3.3 Key Industry Forces (Porter’s) Impacting Market Growth
3.4 Industry Supply Chain Analysis
3.4.1 Raw Material & Component Suppliers
3.4.2 Diagnostic Product & Device Manufacturers
3.4.3 Distributors & Healthcare Supply Providers
3.4.4 End Users / Healthcare Facilities & Patients
3.5 Industry Life Cycle Assessment
4. Statistical Insights & Trends Reporting
4.1 Point-of-Care Testing & Diagnostic Trends (2025)
4.1.1 Global Point-of-Care Testing Volume Statistics
4.1.2 Rapid Diagnostic Testing Adoption Trends
4.1.3 Infectious Disease Testing Trends
4.1.4 Chronic Disease Monitoring Statistics
4.2 Point-of-Care Testing Technology Trends (2025)
4.2.1 Molecular & Nucleic Acid Testing Adoption
4.2.2 Immunoassay-Based Testing Trends
4.2.3 Blood Glucose & Cardiometabolic Testing Trends
4.2.4 Multiplex & Integrated Diagnostic Platform Trends
4.3 Healthcare Delivery & Testing Adoption Trends (2025)
4.3.1 Hospital & Clinic Point-of-Care Testing Statistics
4.3.2 Home-Based & Self-Testing Adoption Trends
4.3.3 Emergency & Critical Care Testing Trends
4.3.4 Decentralized Healthcare Testing Trends
4.4 Regulatory & Clinical Adoption Trends (2025)
4.4.1 Point-of-Care Diagnostic Product Approvals
4.4.2 Regulatory & Clinical Validation Trends
4.4.3 Diagnostic Accuracy & Quality Control Trends
4.4.4 Reimbursement & Healthcare Policy Trends
4.5 Technology & Innovation Trends (2025)
4.5.1 AI-Enabled Point-of-Care Diagnostics Trends
4.5.2 Smartphone-Connected Diagnostic Device Innovation
4.5.3 Miniaturized & Portable Testing Technology Trends
4.5.4 Digital Connectivity & Remote Diagnostic Monitoring Trends
5. Point of Care Diagnostics/Testing Market Segmental Analysis & Forecast, By Product, 2022–2035, Value (USD Billion)
5.1 Introduction
5.2 Infectious Disease Testing
5.2.1 Key Trends
5.2.2 Market Size & Forecast, 2022–2035
5.3 Glucose Monitoring
5.4 Cardiometabolic Testing
5.5 Tumor/Cancer Marker Testing
5.6 Coagulation Testing
5.7 Pregnancy & Fertility Testing
5.8 Others
6. Point of Care Diagnostics/Testing Market Segmental Analysis & Forecast, By Technology/Platform, 2022–2035, Value (USD Billion)
6.1 Introduction
6.2 Lateral Flow Assays
6.2.1 Key Trends
6.2.2 Market Size & Forecast, 2022–2035
6.3 Molecular Diagnostics
6.4 Immunoassays
6.5 Microfluidics
6.6 Dipsticks
7. Point of Care Diagnostics/Testing Market Segmental Analysis & Forecast, By Sample Type, 2022–2035, Value (USD Billion)
7.1 Introduction
7.2 Blood
7.2.1 Key Trends
7.2.2 Market Size & Forecast, 2022–2035
7.3 Urine
7.4 Saliva/Oral Fluid
7.5 Others
8. Point of Care Diagnostics/Testing Market Segmental Analysis & Forecast, By End User, 2022–2035, Value (USD Billion)
8.1 Introduction
8.2 Hospitals
8.2.1 Key Trends
8.2.2 Market Size & Forecast, 2022–2035
8.3 Clinics/Physician Office Labs
8.4 Homecare/Self-Testing
8.5 Others
9. Point of Care Diagnostics/Testing Market Segmental Analysis & Forecast, By Mode of Purchase, 2022–2035, Value (USD Billion)
9.1 Introduction
9.2 Prescription-Based
9.2.1 Key Trends
9.2.2 Market Size & Forecast, 2022–2035
9.3 Over-the-Counter
10. Point of Care Diagnostics/Testing Market Segmental Analysis & Forecast By Region, 2022–2035, Value (USD Billion)
10.1 Introduction
10.2 North America
10.2.1 Key Trends
10.2.2 Point of Care Diagnostics/Testing Market Size & Forecast, By Product, 2022–2035
10.2.3 Point of Care Diagnostics/Testing Market Size & Forecast, By Technology/Platform, 2022–2035
10.2.4 Point of Care Diagnostics/Testing Market Size & Forecast, By Sample Type, 2022–2035
10.2.5 Point of Care Diagnostics/Testing Market Size & Forecast, By End User, 2022–2035
10.2.6 Point of Care Diagnostics/Testing Market Size & Forecast, By Mode of Purchase, 2022–2035
10.2.7 Point of Care Diagnostics/Testing Market Size & Forecast, By Country, 2022–2035
10.2.7.1 USA
10.2.7.2 Canada
10.3 Europe
10.3.1 Key Trends
10.3.2 Point of Care Diagnostics/Testing Market Size & Forecast, By Product, 2022–2035
10.3.3 Point of Care Diagnostics/Testing Market Size & Forecast, By Technology/Platform, 2022–2035
10.3.4 Point of Care Diagnostics/Testing Market Size & Forecast, By Sample Type, 2022–2035
10.3.5 Point of Care Diagnostics/Testing Market Size & Forecast, By End User, 2022–2035
10.3.6 Point of Care Diagnostics/Testing Market Size & Forecast, By Mode of Purchase, 2022–2035
10.3.7 Point of Care Diagnostics/Testing Market Size & Forecast, By Country, 2022–2035
10.3.7.1 Germany
10.3.7.2 UK
10.3.7.3 France
10.3.7.4 Italy
10.3.7.5 Spain
10.3.7.6 Russia
10.3.7.7 Poland
10.3.7.8 Rest of Europe
10.4 Asia-Pacific
10.4.1 Key Trends
10.4.2 Point of Care Diagnostics/Testing Market Size & Forecast, By Product, 2022–2035
10.4.3 Point of Care Diagnostics/Testing Market Size & Forecast, By Technology/Platform, 2022–2035
10.4.4 Point of Care Diagnostics/Testing Market Size & Forecast, By Sample Type, 2022–2035
10.4.5 Point of Care Diagnostics/Testing Market Size & Forecast, By End User, 2022–2035
10.4.6 Point of Care Diagnostics/Testing Market Size & Forecast, By Mode of Purchase, 2022–2035
10.4.7 Point of Care Diagnostics/Testing Market Size & Forecast, By Country, 2022–2035
10.4.7.1 China
10.4.7.2 India
10.4.7.3 Japan
10.4.7.4 South Korea
10.4.7.5 Australia
10.4.7.6 ASEAN Countries
10.4.7.7 Rest of Asia-Pacific
10.5 Latin America
10.5.1 Key Trends
10.5.2 Point of Care Diagnostics/Testing Market Size & Forecast, By Product, 2022–2035
10.5.3 Point of Care Diagnostics/Testing Market Size & Forecast, By Technology/Platform, 2022–2035
10.5.4 Point of Care Diagnostics/Testing Market Size & Forecast, By Sample Type, 2022–2035
10.5.5 Point of Care Diagnostics/Testing Market Size & Forecast, By End User, 2022–2035
10.5.6 Point of Care Diagnostics/Testing Market Size & Forecast, By Mode of Purchase, 2022–2035
10.5.7 Point of Care Diagnostics/Testing Market Size & Forecast, By Country, 2022–2035
10.5.7.1 Brazil
10.5.7.2 Argentina
10.5.7.3 Mexico
10.5.7.4 Colombia
10.5.7.5 Rest of Latin America
10.6 Middle East & Africa
10.6.1 Key Trends
10.6.2 Point of Care Diagnostics/Testing Market Size & Forecast, By Product, 2022–2035
10.6.3 Point of Care Diagnostics/Testing Market Size & Forecast, By Technology/Platform, 2022–2035
10.6.4 Point of Care Diagnostics/Testing Market Size & Forecast, By Sample Type, 2022–2035
10.6.5 Point of Care Diagnostics/Testing Market Size & Forecast, By End User, 2022–2035
10.6.6 Point of Care Diagnostics/Testing Market Size & Forecast, By Mode of Purchase, 2022–2035
10.6.7 Point of Care Diagnostics/Testing Market Size & Forecast, By Country, 2022–2035
10.6.7.1 UAE
10.6.7.2 Saudi Arabia
10.6.7.3 Qatar
10.6.7.4 South Africa
10.6.7.5 Rest of Middle East & Africa
11. Competitive Landscape
11.1 Key Players' Positioning
11.2 Competitive Developments
11.2.1 Year-Wise Strategies & Development, 2022 – 2026
11.3 Market Share Analysis, 2025
11.4 Product/Service & Application Benchmarking
11.4.1 Product/Service Specifications & Features By Key Players
11.4.2 Product/Service Heatmap By Key Players
11.4.3 Application Heatmap By Key Players
11.5 Industry Start-Up & Innovation Landscape
11.6 Key Company Profiles
11.6.1 Abbott Laboratories
11.6.1.1 Company Overview & Snapshot
11.6.1.2 Product/Service Portfolio
11.6.1.3 Key Company Financials
11.6.1.4 Geographical Presence
11.6.1.5 SWOT Analysis
11.6.2 F. Hoffmann-La Roche Ltd.
11.6.3 Danaher Corporation
11.6.4 Siemens Healthineers AG
11.6.5 Becton, Dickinson and Company (BD)
11.6.6 Thermo Fisher Scientific Inc.
11.6.7 Sysmex Corporation
11.6.8 Bio-Rad Laboratories, Inc.
11.6.9 QuidelOrtho Corporation
11.6.10 bioMérieux SA
11.6.11 Chembio Diagnostics, Inc.
11.6.12 Trinity Biotech plc
11.6.13 PTS Diagnostics
11.6.14 Nova Biomedical
11.6.15 OraSure Technologies, Inc.
11.6.16 Sekisui Diagnostics
11.6.17 Cepheid (Danaher)
11.6.18 Instrumentation Laboratory (Werfen)
11.6.19 Sight Diagnostics
11.6.20 EKF Diagnostics Holdings plc
12. Analyst Recommendations
12.1 SNS Insider Opportunity Map
12.2 Industry Low-Hanging Fruit Assessment
12.3 Market Entry & Growth Strategy
12.4 Analyst Viewpoint & Suggestions On Market Growth
13. Assumptions
14. Disclaimer
15. Appendix
15.1 List Of Tables
15.2 List Of Figures
Frequently Asked Questions
Key players in the Point of Care Diagnostics/Testing Market include Abbott Laboratories, F. Hoffmann-La Roche Ltd., Danaher Corporation, Siemens Healthineers AG, and Becton, Dickinson and Company (BD), among others.
-
Key opportunities in the Point of Care Diagnostics/Testing Market include integration with wearables and mobile health platforms for continuous patient monitoring and AI-assisted result interpretation extending rapid testing into less specialized care settings.
The market is driven by rising global prevalence of chronic conditions requiring frequent monitoring, combined with continued infectious disease burden and the ongoing shift toward decentralized, near-patient healthcare delivery.
The Infectious Disease Testing segment dominated the Point of Care Diagnostics/Testing Market, accounting for approximately 30.50% market share.
North America dominated the Point of Care Diagnostics/Testing Market in 2025 with approximately 37.10% share, driven by a large hospital network and strong retail pharmacy testing adoption.